active
Laboratory surveillance - Vaccines
Bangladesh - United States of America
Project timeline: 01/09/2020 - 31/08/2025
Lead Researcher: Prof. Edward Ryan
Organisation / Institution: Harvard University, and Massachusetts General Hospital
Funders: NIH - National Institutes of Health
This project focuses on defining O-specific polysaccharide (OSP) responses during cholera and development of vaccines protective against cholera and enteric infection.
Immune responses that mediate protection against cholera target the sugar (OSP) that coats the bacteria that causes cholera. Young children in particular do not develop high level or durable immune responses against this sugar after oral cholera vaccination. Understanding and improving these responses will be critical in development of next generation cholera vaccines that can protect young children against cholera, and that can be incorporated in EPI schedules.
Informs development of next generation cholera vaccines for use in children under 5 years of age.
Firdausi Qadri, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)
International Vaccine Institute, Seoul, South Korea